Randomness and biospecificity: Random copolymers are capable of biospecific molecular recognition in living systems

Biomaterials

Volumn 18, Issue 24, 1997, Pages 1633-1644

  Jozefowicz, Marcel ^a   Jozefonvicz, Jacqueline ^a  

^a CNRS   (France)

Author keywords

Biomaterials; Biospecificity; DNA like; Heparin like; Random copolymers

Indexed keywords

BIOMATERIALS; COMPUTER SIMULATION; COPOLYMERS; MONTE CARLO METHODS;

BIOSPECIFICITY; RANDOM COPOLYMERS;

DNA;

BIOMATERIAL; COPOLYMER; HEPARIN; MONOMER; POLYMER; POLYSTYRENE;

ARTICLE; CELL GROWTH; CELL METABOLISM; MOLECULAR RECOGNITION; PHOSPHORYLATION; POLYMERIZATION; PRIORITY JOURNAL; PROBABILITY; SYSTEM ANALYSIS;

ANIMALS; ANTICOAGULANTS; BIOCOMPATIBLE MATERIALS; COMPLEMENT INACTIVATOR PROTEINS; DEXTRANS; DNA; HEPARIN; HUMANS; MONTE CARLO METHOD; PLATELET AGGREGATION INHIBITORS; POLYMERS; POLYSTYRENES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031432321     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(97)00145-2     Document Type: Article

References (82)

1. 1. The Total Synthesis of Natural Products. Simon, J. Ap. ed. J. Wiley, New York 1973-1988; Vol 1-7.
2. 2. Choay, J. Petitou, M., Lormeau, J. C., Sinay, P., Casie, B. and Gatti, G., Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. Biochem. Biophys. Res. Comm. 1983, 116, 492-499.
3. 3. Van Boeckel, C. A. A. and Petitou, M., The unique antithrombin III binding domain of heparin: a lead to new synthetic antithrombotics. Angew. Chem. Int. Ed. Engl., 1993, 32, 1671-1690.
4. 4. Monod, J. Le hasard et la nécessité, ed. J. Monod. Edition du Seuil, Paris, 1970, pp. 1-213.
5. 5. Horbett, T. and Brash, J. L., Proteins at Interfaces. Physicochemical and Biochemical Studies, ed. J. L. Brash and T. Horbett. ACS Symposium Series 343, American Chemical Society, Washington DC, 1987.
6. 6. Andrade, J. D. and Hlady, V., Vroman effects techniques, and philosophies. J. Biomater. Sci. Polym. Edn., 1991, 2, 161-172.
7. 7. Gott, V. L., Whiffen, J. D. and Dutton, R. C., Heparin bonding on colloïdal graphite surfaces. Science, 1963, 142, 1297-1305.
8. 8. Leininger, R. I., Cooper, C. W., Falb, R. D. and Grode, G. A., Non-thrombogenic plastic surfaces. Science, 1966, 152, 1622-1625.
9. 9. Merril, E. W., Salzman, E. W., Wong, P. S. L., Ashford, T. P., Brown, A. H. and Austen, W. G., Polyvinyl alcohol-heparin hydrogel 'G'. J. Appl. Physiol., 1969, 29, 723-730.
10. 10. Hoffman, A. S., Schmer, G., Harris, C. and Kraft, W. C., Covalent binding of biomolecules to radiation-grafted hydrogels on inert polymer surfaces. Trans. Am. Soc. Artif. Intern. Organs., 1972, 18, 10-18.
11. 11. Labarre, D., Boffa, M. C. and Jozefowicz, M., Preparation and properties of heparin-poly (methylmethacrylate) copolymers. Polym. Sci. Symp. 1974, 47, 131-137.
12. 12. Baquey, Ch., Beziade, A., Ducassou, D. and Blanquet, P., Intérêt du greffage radiochimique de monomères vinyliques pour améliorer l'hémocompatibilité de matériaux artificiels. Innov. Tech. Biol. Med. 1981, 2, 379-389.
13. 13. Ferruti, P., Barbucci, R., Danzo, N. et al., Preparation and ESCA characterization with heparin-complexing poly (amidoamine) chains. Biomaterials, 1982, 3, 33-37.
14. 14. Ebert, D. and Kim, S. W., Immobilized heparin: spacer arm effects on biological interactions. Thromb. Res. 1982, 26, 43-57.
15. 15. Goosen, M. F. A. and Sefton, M. V., Properties of a heparin-poly (vinyl alcohol) hydrogel coating. J. Biomed. Mater. Res. 1983, 17, 359-373.
16. 16. Larm, O., Larsson, R. and Olsson, M. D., A new nonthrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomat. Med. Dev. Art. Org. 1983, 11, 161-173.
17. 17. Brandley, B. K. and Schnaar, R. L., Covalent attachment of an arg-gly-asp sequence peptide to derivatizable polyacrylamide surfaces: support of fibroblast adhesion and long-term growth. Anal. Biochem. 1988, 172, 270-278.
18. 18. Massia, S. P. and Hubbell, J. A., Covalent surface immobilization of arg-gly-asp-and tyr-ile-gly-ser-arg-containing peptides to obtain well-defined cell-adhesive substrates. Anal. Biochem. 1990, 187, 292-302.
19. 19. Kugo, K., Okuno, M., Masuda, K., Nishino, J., Masuda, H. and Iwatsuku, M., Fibroblast attachment to Arg-Gly-Asp peptide-immobilized poly (γ-methyl L-glutamate). J. Biomater. Sci. Polym. Edn. 1994, 5, 325-337.
20. 20. Lin, H. B., Lewis, K. B., Leach-Scampania, D., Ratner, B. D. and Cooper, S. L., Surface properties of RGD-peptide grafted polyurethane blood copolymers: variable take-off angle and cold stage ESCA studies. J. Biomater. Sci. Polym. Edn. 1993, 4, 183-198.
21. 21. Yamada, K. M. and Kennedy, D. W., Analistic nature of adhesive protein function: fibronectin and its biologically active peptide fragments can autoinhibit fibronectin function. J. Cell Biol., 1994, 99, 29-36.
22. 22. Pierschbacher, M. D. and Ruoslahti, E., Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature, 1984, 309, 30-33.
23. 23. Besselink, G. A. J., Beugelina, T., Beernink, R., Poot, A. A., Van Aken, W. G. and Bantyes, A., The binding of human blood platelets to fibrinogen; fibronectin; and Arg-Gly-Asp-derivatized Sephadex G-10. J. Biomater. Sci. Polym. Edn. 1995, 7, 551-562.
24. 24. Sank, A., Rostanu, K., Weaver, F. et al., New evidence and new hope concerning endothelial seeding of vascular grafts. Am. J. Surg. 1992, 164, 199-204.
25. 25. Woodhouse, K. A., Weitz, J. I. and Brash, J. L., Interaction of plasminogen and fibrinogen with model silica glass surfaces: adsorption from plasma and enzymatic activity studies. J. Biomed. Mater. Res., 1994, 28, 407-415.
26. 26. Fougnot, C., Jozefonvicz, J., Samama, M. and Bara, L., New heparin-like insoluble materials I. Ann. Biomed. Eng., 1979, 7, 429-439.
27. 27. Fougnot, C., Jozefowicz, M. Samama, M. and Bara, L., New heparin-like insoluble materials II. Ann. Biomed. Eng. 1979, 7, 441-450.
28. 28. Jozefowicz, M., Jozefonvicz, J., Fougnot, C. and Labarre, D., New heparin-like insoluble materials. In Chemistry and Biology of Heparin ed. R. L. Lundblad et al. Elsevier North Holland, Inc., Amsterdam 1981, pp. 475-485.
29. 29. Douzon, C., Kanmangne, F. M., Serne, H., Labarre, D. and Jozefowicz, M., Heparin-like activity of insoluble sulphonated polystyrene resins. Part III: Binding of dicarboxylic aminoacids. Biomaterials, 1987, 8, 190-194.
30. 30. Fougnot, C., Jozefowicz, M. and Rosenberg, R. D., Adsorption of purified thrombin or antithrombin III for two insoluble anticoagulant polystyrene derivatives: II. Competition with the other plasma proteins. Biomaterials, 1984, 5, 89-93.
31. 31. Fougnot, C., Jozefowicz, M. and Rosenberg, R. D., Catalysis of the generation of thrombin-antithrombin complex by insoluble anticoagulant polystyrene derivatives. Biomaterials, 1984, 5, 94-99.
32. 32. Fougnot, C., Dupillier, M. P. and Jozefowicz, M., Anticoagulant activity of amino acid modified polystyrene resins: influence of the carboxylic acid function. Biomaterials, 1983, 4, 101-104.
33. 33. Migonney, V., Fougnot, C. and Jozefowicz, M., Heparin-like tubings I. Preparation, characterization and biological in vitro activity assessment. Biomaterials, 1988, 9, 145-149.
34. 34. Migonney, V., Fougnot, C. and Jozefowicz, M., Heparin-like tubings III. Kinetics and mechanism of thrombin, antithrombin III and thrombin-antithrombin complex adsorption under controlled-flow conditions. Biomaterials, 1988, 9, 413-418.
35. 35. Migonney, V., Fougnot, C. and Jozefowicz, M., Heparin-like tubins II. Mechanism of the thrombin-antithrombin III reaction at the surface. Biomaterials, 1988, 9, 230-234.
36. 36. Mauzac, M., Aubert, N. and Jozefonvicz, J., Antithrombic activity of some polysaccharide resins. J. Biomater., 1982, 3, 221-224.
37. 37. Aubert, N., Mauzac, M. and Jozefonvicz, J., Anticoagulant hydrogels derived from crosslinked dextran. Part I: synthesis, characterization and antithrombic activity. Biomaterials, 1987, 8, 24-29.
38. 38. Jozefowicz, M. and Jozefonvicz, J., Antithrombogenic polymers. Pure Appl. Chem., 1984, 56, 1335-1344.
39. 39. Jozefonvicz, J., Mauzac, M., Aubert, N. and Jozefowicz, M., Antithrombogenic activity of polysaccharide resins. In Biocompatibility of Tissue Analogs, ed. D. F. Williams. CRC Press, Boca Raton, FL, 1985, pp. 133-152.
40. 40. Aubert, N., Mauzac, M., Gulino, D. and Jozefonvicz, J., Anticoagulant hydrogels derived from crosslinked dextran. Part II: mechanism of thrombin inactivation. Biomaterials, 1987, 8, 100-103.
41. 41. Mauzac, M. and Jozefonvicz, J., Anticoagulant activity of dextran derivatives. Part I: synthesis and characterization. Biomaterials, 1984, 5, 301-304.
42. 42. Fischer, A, M., Mauzac, M., Tapon-Bretaudiere, J. and Jozefonvicz, J., Anticoagulant activity of dextran derivatives. Part II: Mechanism of thrombin inactivation. Biomaterials, 1985, 6, 198-202.
43. 43. Mauzac, M., Maillet, F., Jozefonvicz, J. and Kazatchkine, M. D. Anticomplementary activity of dextran derivatives. Biomaterials, 1985, 6, 61-63.
44. 44. Crepon, B., Maillet, F., Kazatchkine, M. D. and Jozefonvicz, J., Molecular weight dependency of the acquired anticomplementary and anticoagulant activities of specifically substituted dextrans. Biomaterials, 1987, 8, 248-253.
45. 45. Thomas, H., Maillet, F., Letourneur, D., Jozefonvicz, J. and Kazatchkine, M. D., Effect of substituted dextran derivative on complement activation in vivo. Biomaterials, 1995, 16, 1163-1167.
46. 46. Jozefonvicz, J. and Jozefowicz, M., Polymeric drug and drug delivery systems. In Polymeric Biomaterials, ed. S. Dumitriu, Marcel Dekker Inc., New York, 1994, pp. 349-371.
47. 47. Carreno, M. P., Labarre, D., Jozefowicz, M. and Kazatchkine, M. D., The ability of Sephadex to activate human complement is suppressed in specifically substituted functional Sephadex derivatives. Mol. Immunol. 1988, 25, 165-171.
48. 48. Montdargent, B., Toufik, J., Carreno, M. P., Labarre, D. and Jozefowicz, M., Complement activation and adsorption of protein fragments by functionalized polymer surfaces in human serum. Biomaterials, 1992, 13, 571-576.
49. 49. Boisson, C., Gulino, D., Jozefonvicz, J., Fischer, A. M. and Tapon-Bretaudiere, J., Antithrombic properties of insoluble modified polystyrene: Part I. Thromb. Res. 1984, 34, 269-276.
50. 50. Fischer, A. M., Yu, X. J., Tapon-Bretaudiere, J., Muller, D., Bros, A. and Jozefonvicz, J., Thrombin purification by one-step preparative affinity chromatography on modified polystyrenes. J. Chromatogr. 1986, 363, 95-100.
51. 51. Muller, D., Yu, X. J., Fischer, A. M., Bros, A. and Jozefonvicz, J., High-performance affinity chromatography of human thrombin on modified polystyrene resins. J. Chromatogr. 1986, 359, 351-357.
52. 52. Yu, X. J., Fischer, A. M., Muller, D., Bros, A., TaponBretaudiere, J. and Jozefonvicz, J., Affinity chromatography of thrombin on modified polystyrene resins. J. Chromatogr. 1986, 376, 429-435.
53. 53. Boisson, C., Gulino, D. and Jozefonvicz, J., Affinity of antithrombin III for insoluble modified polystyrene. Thromb. Res. 1987, 46, 101-108.
54. 54. Boisson, C., Jozefonvicz, J. and Brash, J. L., Adsorption of thrombin from buffer and modified plasma to polystyrene resins containing sulphonate and sulphamide arginyl methyl ester groups. Biomaterials, 1988, 9, 47-52.
55. 55. Boisson-Vidal, C., Jozefonvicz, J. and Brash, J. L., Interaction of antithrombin III in purified solution and in plasma with insoluble modified polystyrene. Colloids Surf. B: Biointerfaces, 1993, 1, 177-187.
56. 56. Boisson-Vidal, C., Messaikeh, H. and Jozefonvicz, J., Adsorption of human antibodies to factor VIII: C to insoluble modified polystyrene from plasma. J. Mater. Sci. Mater, Medicine 1991, 2, 193-196.
57. 57. Dahri, L., Boisson-Vidal, C., Muller, D. and Jozefonvicz, J., Tyrosyl sulfamide derivatives as ligands for affinity adsorption of anti FVIII antibodies. J. Biomater. Sci. Polym. Edn., 1994, 6, 695-705.
58. 58. Jozefowicz, M. and Jozefonvicz, J., Randomness and biospecificity: random copolymers are endowed with biospecific properties. In Advanced Biomaterials in Biomedical Engineering and Drug Delivery Systems, ed. N. Ogata, S. W. Kim, J. Feijen and T. Okano. Springer, Tokyo, 1996, pp. 147-152.
59. 59. Letourneur, D., Douzon, C. and Jozefowicz, M., Synthesis and characterization of phosphorylated polystyrene derivatives for use in chromatography: DNA-like and phospholipid-like behavior. J. Polym. Sci. Part A: Polym. Chem., 1991, 29, 1367-1377.
60. 60. Letourneur, D. and Jozefowicz, M., Insoluble DNA-like phosphorylated polystyrene: specific interactions with anti-DNA antibodies from systemic lupus erythematosus patients. Biomaterials, 1992, 13, 59-63.
61. 61. Migonney, V., Souirti, A., Pavon-Djavid, G., Pflüger, F. and Jozefowicz, M., Biospecific polymers: recognition of phosphorylated polystyrene derivatives by anti-DNA antibodies. J. Biomater. Sci. Polym. Edn., 1997, 8, 533-544.
62. 62. Aubert, N., Reach, G., Serne, H. and Jozefowicz, M., Reversible morphological and functional abnormalities of RINm5F cells cultured on polystyrene sulfonate beads. J. Biomed. Mater. Res., 1987, 21, 585-601.
63. 63. Oturan, N., Serne, H., Reach, G. and Jozefowicz, M., RINm5F cell culture on Sephadex derivatives. J. Biomed. Mater. Res., 1993, 27, 705-715.
64. 64. Letourneur, D., Champion, J., Slaoui, F. and Jozefonvicz, J., In vitro stimulation of human endothelial cells by derivatized dextrans. In Vitro Cell. Dev. Biol. 1993, 29A, 67-72.
65. 65. Najab-Benhayoun, M., Serne, H., Jozefowicz, M., Fischer, A. M., Brisson, C. and Sultan, Y., Human umbilical vein endothelial cell culture on heparin-like microcarriers. J. Biomed. Mater. Res., 1993, 27, 511-520.
66. 66. Stanilawski, L., Serne, H., Stanilawski, M. and Jozefowicz, M., Conformational changes of fibronectin induced by polystyrene derivatives with a heparin-like function. J. Biomed. Mater. Res., 1993, 27, 619-626.
67. 67. Vaudaux, P., Avramoglou, T., Letourneur, D., Lew, D. P. and Jozefonvicz, J., Inhibition by heparin and derivatized dextrans of Staphylococcus aureus adhesion to fibronectin-coated biomateriak. J. Biomater. Sci. Polym. Edn. 1992, 4, 89-97.
68. 68. Tardieu, M., Slaoui, F., Jozefonvicz, J., Courty, J., Gamby, C. and Barritault, D., Biological and binding studies of acidic fibroblast growth factor in the presence of substituted dextran. J. Biomater. Sci. Polym. Edn, 1989, 1, 63-70.
69. 69. Tardieu, M., Gamby, C., Avramoglou, T., Jozefonvicz, J. and Barritault, D., Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGF. J. Cell Phys. 1992, 150, 194-203.
70. 70. Jacquot-Dourges, M. A., Gulino, D., Courty, J. Badet, J. Barritault, D. and Jozefonvicz, J., Affinity chromatography of fibroblast growth factors on substituted polystyrene. J. Chromatogr. 1990, 526, 35-45.
71. 71. Avramoglou, T. and Jozefonvicz, J., Derivatized dextran inhibition of smooth muscle cell proliferation. J. Biomater. Sci. Polym. Edn., 1991, 3, 149-154.
72. 72. Letourneur, D., Logeart, D., Avramoglou, T. and Jozefonvicz, J., Antiproliferative capacity of synthetic dexrtrans on smooth muscle cell growth: the model of derivatized dextrans as heparin-like polymers. J. Biomater. Sci. Polym. Edn., 1993, 4, 431-444.
73. 73. Logeart, D., Avramoglou, T. and Jozefonvicz, J., Inhibitory effect of functional dextrans on rat arterial smooth muscle cell growth in vitro. Colloïds Surf. B: Biointerfaces, 1994, 2, 315-322.
74. 74. Imbert, E., Souirti, A., Menard, V., Pfluger, F., Jozefowicz, M. and Migonney, V., DNA-like and phospholipid-like phosphorylated polystyrene: characterization, distribution of functional groups, and calcium complexation properties. J. Appl. Polym. Sci., 1994, 52, 91-97.
75. 75. Litmanovich, A. D., Change of polymer reactivity in the course of macromolecular reaction. Eur. Polym. J., 1980, 16, 269-275.
76. 76. Molecular Biology of the cells, ed. B. Albert et al. Garland, New York, 1983.
77. 77. Rauch, J., Tannenbaum, H., Stollar, B. D. and Schwartz, R. S., Monoclonal anti-cardiolipin antibodies bind to DNA. Eur. J. Immunol. 1984, 14, 529-534.
78. 78. Jordan, R., Beeler, D. and Rosenberg, R. D., Fractionation of low molecular weight heparin species and their interaction with antithrombin. J. Biol. Chem., 1979, 254, 2902-2913.
79. 79. Morere, J. F., Letourneur, D., Planchon, P., Avramoglou, T., Jozefonvicz, J., Israel, L. and Crépin, M., Inhibitory effect of substituted dextrans on MCF7 human breast cancer cell growth in vitro. Anti-Cancer Drugs, 1992, 3, 629-634.
80. 80. Fougnot, C., Jozefowicz, M. and Rosenberg, R. D., Affinity of purified thrombin or antithrombin III for two insoluble anticoagulant polystyrene derivatives: I. In vitro adsorption studies. Biomaterials, 1983, 4, 294-298.
81. 81. Fougnot, C., Jozefowicz, M., Bara, L. and Samama, M., Interactions of anticoagulant insoluble modified polystyrene resins with plasmatic proteins. Throm. Res., 1982, 28, 37-46.
82. 82. Andrade, J. D., Needs, problems and opportunities in biomaterials and biocompatibility. Clin. Mater., 1992, 11, 19-23.